Trial Profile
KEVZARA Special Drug Use Investigation
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Sarilumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Acronyms KEVZARA
- Sponsors Sanofi K.K.
- 05 Nov 2021 Status changed from recruiting to active, no longer recruiting.
- 02 Nov 2020 Status changed from active, no longer recruiting to recruiting.
- 02 Nov 2020 Planned End Date changed from 31 May 2020 to 30 Nov 2024.